Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06542653

Effect of PCI on Clinical Prognosis of Chronic Coronary Artery Occlusion

Status
Recruiting
Phase
Study type
Observational
Enrollment
258 (estimated)
Sponsor
The First Affiliated Hospital with Nanjing Medical University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Coronary chronic total occlusions (CTOs) are considered to increase the risk of adverse clinical outcomes. The purpose of this study was to evaluate whether long-term clinical outcomes could be improved by successful percutaneous coronary intervention (PCI) over optimal medical therapy (OMT) in CTO patients.

Detailed description

patients with CTO lesions undergoing PCI at the First Affiliated Hospital of Nanjing Medical University from January 2011 to December 2017 were enrolled. After someone were excluded due to CABG surgery, patients who met the enrollment criteria were divided into successful CTO-PCI group and CTO-OMT group based on the treatment received. The study primary endpoint was major adverse cardiac cerebrovascular events (MACCE), including cardiac death, recurrent myocardial infarction, unplanned revascularization, and stroke. The secondary endpoint was all-cause death.

Conditions

Interventions

TypeNameDescription
PROCEDUREPCIsuccessful percutaneous coronary intervention (PCI) in Coronary chronic total occlusions (CTOs) patients
DRUGOMToptimal medical therapy (OMT) in CTO patients, such as aspirin 1td, ACEI/ARB 1td, β blocker 1td, statin 1td.

Timeline

Start date
2023-09-17
Primary completion
2024-09-17
Completion
2025-09-17
First posted
2024-08-07
Last updated
2024-12-27

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06542653. Inclusion in this directory is not an endorsement.